SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001724521-24-000079
Filing Date
2024-04-23
Accepted
2024-04-23 16:08:51
Documents
20
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A rcus-20240423.htm   iXBRL DEF 14A 887055
6 rcus-20240423_g1.jpg GRAPHIC 23865
7 rcus-20240423_g2.jpg GRAPHIC 31830
8 rcus-20240423_g3.jpg GRAPHIC 64465
9 rcus-20240423_g4.jpg GRAPHIC 67545
10 rcus-20240423_g5.jpg GRAPHIC 127654
11 rcus-20240423_g6.jpg GRAPHIC 104341
  Complete submission text file 0001724521-24-000079.txt   2512580

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20240423.xsd EX-101.SCH 2626
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rcus-20240423_def.xml EX-101.DEF 2292
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20240423_lab.xml EX-101.LAB 2785
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20240423_pre.xml EX-101.PRE 1373
23 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20240423_htm.xml XML 126199
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38419 | Film No.: 24864891
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)